Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Hoosien

Reversal of Pathological Cardiac Hypertrophy via the MEF2-coregulator Interface

English

Related publications

Tripartite Motif 32 Prevents Pathological Cardiac Hypertrophy

Clinical Science

English

Nuclear GAPDH Signaling Mediates Pathological Cardiac Hypertrophy

English

The Transcription Factor GATA-6 Regulates Pathological Cardiac Hypertrophy

Circulation Research

Cardiovascular Medicine

English

CaM Kinase Signaling Induces Cardiac Hypertrophy and Activates the MEF2 Transcription Factor in Vivo

Journal of Clinical Investigation

English

The H3K9 Dimethyltransferases EHMT1/2 Protect Against Pathological Cardiac Hypertrophy

Journal of Clinical Investigation

English

Mechanisms for the Transition From Physiological to Pathological Cardiac Hypertrophy

Canadian Journal of Physiology and Pharmacology

English

Fibronectin Contributes to Pathological Cardiac Hypertrophy but Not Physiological Growth

Basic Research in Cardiology

Cardiovascular Medicine

English

Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy

Internal Medicine

English

Tom70 Serves as a Molecular Switch to Determine Pathological Cardiac Hypertrophy

Molecular Biology

English